Web Stats Provided By Google Analytics

Monday, April 24, 2017

Sanofi and Regeneron Receive CHMP Positive Opinion for KevzaraA ...

Sanofi and Regeneron Receive CHMP Positive Opinion for KevzaraA to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Paris, France and Tarrytown, New York - April 24, 2017 - Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Kevzara , recommending its approval for use in adult patients with moderately to severely active rheumatoid arthritis. Kevzara is an investigational human monoclonal antibody directed against the IL-6 receptor.
http://ift.tt/2pUVyot

No comments:

Post a Comment

Popular Tarrytown Roundup Posts